OLIVIER J. WOUTERS

Economics, Econometrics and FinancePharmacology, Toxicology and PharmaceuticsHealth ProfessionsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval”.

Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval

The Milbank Quarterly(2017)10.1111/1468-0009.12261

N/A

3.2DataRank · unranked

59 citations

OLIVIER J. WOUTERS, RADHIKA GUPTA, John P. A. Ioannidis, Huseyin Naci

Revenue Differences Between Top-Selling Small-Molecule Drugs and Biologics in Medicare

JAMA Health Forum(2025)10.1001/jamahealthforum.2025.4720

N/A

0DataRank · unranked

0 citations

William B. Feldman, Zander Cowan, Benjamin N. Rome, Amitabh Chandra, Aaron S. Kesselheim +2 more